Hide metadata

dc.contributor.authorSchaner, Marci E
dc.contributor.authorDavidson, Ben
dc.contributor.authorSkrede, Martina
dc.contributor.authorReich, Reuven
dc.contributor.authorFlørenes, Vivi A
dc.contributor.authorRisberg, Björn
dc.contributor.authorBerner, Aasmund
dc.contributor.authorGoldberg*, Iris
dc.contributor.authorGivant-Horwitz, Vered
dc.contributor.authorTropè, Claes G
dc.contributor.authorKristensen, Gunnar B
dc.contributor.authorNesland, Jahn M
dc.contributor.authorBørresen-Dale, Anne-Lise
dc.date.accessioned2015-10-09T01:05:14Z
dc.date.available2015-10-09T01:05:14Z
dc.date.issued2005
dc.identifier.citationMolecular Cancer. 2005 Jul 21;4(1):26
dc.identifier.urihttp://hdl.handle.net/10852/46420
dc.description.abstractBackground While numerous studies have characterized primary ovarian tumors, little information is available regarding expression patterns of metastatic sites of this cancer. To define sets of genes that distinguish primary and metastatic ovarian tumors, we used cDNA microarrays to characterize global gene expression patterns in 38 effusions (28 peritoneal, 10 pleural) and 8 corresponding primary ovarian tumors, and searched for associations between expression patterns and clinical parameters. Results We observed multidimensional variation in expression patterns among the cancers. Coordinate variation in expression of genes from two chromosomal regions, 8q and 19q, was seen in subsets of the cancers indicating possible amplifications in these regions. A set of 112 unique genes of known function was differentially expressed between primary tumors and effusions using supervised analysis. Relatively few differences were seen between effusions isolated from the pleural and peritoneal cavities or between effusions from patients diagnosed with stage III and stage IV cancers. A set of 84 unique genes was identified that distinguished high from lower grade ovarian cancers. The results were corroborated using immunocytochemistry, mRNA in situ hybridization, and immunoblotting. Conclusion The extensive variation in expression patterns observed underscores the molecular heterogeneity of ovarian cancer, but suggests a similar molecular profile for ovarian carcinoma cells in serosal cavities.
dc.language.isoeng
dc.rightsSchaner et al; licensee BioMed central Ltd.
dc.rightsAttribution 2.0 Generic
dc.rights.urihttp://creativecommons.org/licenses/by/2.0/
dc.titleVariation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
dc.typeJournal article
dc.date.updated2015-10-09T01:05:15Z
dc.creator.authorSchaner, Marci E
dc.creator.authorDavidson, Ben
dc.creator.authorSkrede, Martina
dc.creator.authorReich, Reuven
dc.creator.authorFlørenes, Vivi A
dc.creator.authorRisberg, Björn
dc.creator.authorBerner, Aasmund
dc.creator.authorGoldberg*, Iris
dc.creator.authorGivant-Horwitz, Vered
dc.creator.authorTropè, Claes G
dc.creator.authorKristensen, Gunnar B
dc.creator.authorNesland, Jahn M
dc.creator.authorBørresen-Dale, Anne-Lise
dc.identifier.doihttp://dx.doi.org/10.1186/1476-4598-4-26
dc.identifier.urnURN:NBN:no-50597
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/46420/1/12943_2005_Article_115.pdf
dc.type.versionPublishedVersion
cristin.articleid26


Files in this item

Appears in the following Collection

Hide metadata

Attribution 2.0 Generic
This item's license is: Attribution 2.0 Generic